Favipiravir for the prevention and management of COVID‐19: evidence review of the clinical benefit and harm

Blockman, M.Cohen, K. De Waal, R.Gray, A.Kredo, T.Maartens, G.Nel, J.Parrish, A.Rees, H.Reubenson, G.2020-07-202020-07-202020-06-25https://infospace.mrc.ac.za/handle/11288/595267enAttribution 3.0 United Stateshttp://creativecommons.org/licenses/by/3.0/us/Favipiravir for the prevention and management of COVID‐19: evidence review of the clinical benefit and harmArticle